ED

Esuru Debaraju Reddy

Active Director Managing Director DIN 10846202
DIN 10846202 First appointment Nov 2024 Primary industry Oil & Gas
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Esuru Debaraju Reddy

Data last updated:

Esuru Debaraju Reddy is a Managing Director at Revola Pharmaceuticals Private Limited (since 2024). The company operates in Oil & Gas.

DIN 10846202
Primary Designation Managing Director
Industry Oil & Gas
First Appointment 21 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director21 Nov 20242024Active

Directorship timeline

Open interactive timeline →
Revola Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Esuru Debaraju Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Esuru Debaraju Reddy

Esuru Debaraju Reddy currently holds 1 directorship: Revola Pharmaceuticals Private Limited (Managing Director, since 21 Nov 2024).

Esuru Debaraju Reddy was first appointed on 21 Nov 2024 as Managing Director at Revola Pharmaceuticals Private Limited.

The current boards of Esuru Debaraju Reddy's companies include Dillip Kumar Mohanty (Revola Pharmaceuticals Private Limited), Jeeru Ganesh (Revola Pharmaceuticals Private Limited), Sumana Talakokkula (Revola Pharmaceuticals Private Limited), Sunkireddy Nagamani (Revola Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available